Pomolic acid, triterpenoid isolated from Licania pittieri, as competitive antagonist of ADP-induced aggregation of human platelets

Phytomedicine

Volumn 19, Issue 6, 2012, Pages 484-487

  Alvarado Castillo, Claudia ^a   Estrada, Omar ^a   Carvajal, Edilmo ^b  

^a INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

Author keywords

ADP receptors; Competitive antagonist; Human platelets; Pomolic acid

Indexed keywords

4 (2 IODO 6 METHYLAMINO 9H PURIN 9 YL) 2 PHOSPHONOOXYBICYCLO[3.1.0]HEXANE 1 METHANOL; ADENOSINE DIPHOSPHATE; ANTITHROMBOCYTIC AGENT; MRS 2365; POMOLIC ACID; PURINERGIC P2Y RECEPTOR AGONIST; PURINERGIC P2Y1 RECEPTOR; PURINERGIC P2Y12 RECEPTOR; TRITERPENOID; UNCLASSIFIED DRUG;

ARTICLE; HUMAN; HUMAN CELL; IN VITRO STUDY; LICANIA PITTIERI; MEDICINAL PLANT; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE SHAPE;

ADENOSINE DIPHOSPHATE; CHRYSOBALANACEAE; DRUG EVALUATION; EPINEPHRINE; HUMANS; OLEANOLIC ACID; PHYTOTHERAPY; PLANT LEAVES; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS;

LICANIA;

EID: 84859211747     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2011.12.011     Document Type: Article

References (13)

1. O. Arunlakshana, and H.O. Schild Some quantitative uses of drug antagonism British Journal of Pharmacology 14 1959 48 58
2. V. Calderone, B. Baragatti, M.C. Breschi, and E. Martinotti Experimental and theoretical comparisons between the classical Schild analysis and a new alternative to evaluate the pA2 of competitive antagonists Naunyn-Schmiedeberg's Archives of Pharmacology 360 1999 477 487
3. A.M. Díaz, M.J. Abad, L. Fernández, C. Recuero, L. Villaescusa, A.M. Silván, and P. Bermejo In vitro anti-inflammatory activity of iridoids and triterpenoid compounds isolated from Phillyrea latifolia L. Biological Pharmaceutical Bulletin 23 2000 1307 1313
4. O. Estrada, C. Alvarado-Castillo, A. Fernández, M. López, E. Romero-Vecchione, J. Vásquez, J. Méndez, D. Conde, and A. Cardozo Pomolic acid isolated from the leaves of Licania pittieri inhibits ADP- and epinephrine-induced platelet aggregation and has hypotensive effect on rats Current Bioactive Compounds 5 2009 219 225
5. M. Franchini, and P.M. Mannucci New antiplatelet agents: why they are needed European Journal of Internal Medicine 20 2009 733 738
6. E.M. Giner-Larza, M. Salvador, M.C. Recio, R.M. Giner, J.M. Prieto, M. Cerda-Nicolas, and J.L. Rios Oleanonic acid, a 3-oxotriterpene from Pistacia, inhibits leukotriene synthesis and has anti-inflammatory activity European Journal of Pharmacology 428 2001 137 143
7. B. Hechler, A. Eckly, P. Ohlmann, J.P. Cazenave, and C. Gachet The P2Y1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel British Journal of Haematology 103 1998 858 866
8. J.L. Jin, S. Lee, Y.Y. Lee, J.M. Kim, J.E. Heo, and H.S. Yun-Choi Platelet anti-aggregating triterpenoids from the leaves of Acanthopanax senticosus and the fruits of A. sessiliflorus Planta Medica 70 2004 564 566
9. J.L. Jin, Y.Y. Lee, J.E. Heo, S. Lee, J.M. Kim, and H.S. Yun-Choi Anti-platelet pentacyclic triterpenoids from leaves of Campsis grandiflora Archives of Pharmacal Research 27 2004 v376 v380
10. K.A. Jacobson, A.A. Ivanov, S. De Castro, T.K. Harden, and H. Ko Development of selective agonists and antagonists of P2Y receptors Purinergic Signalling 5 2009 75 89
11. F. Lanza, A. Beretz, A. Stierlé, D. Hanau, M. Kubina, and J.P. Cazenave Epinephrine potentiates human platelet activation but is not an aggregating agent American Journal of Physiology 255 1988 H1276 H1288
12. H.J. Motulkys, and A. Christopoulus Fitting Models to Biological Data using Linear and Nonlinear Regression. A Practical Guide to Curve Fitting 2003 Graph Pad Software Inc. San Diego www.graphpad.com
13. H.S. Yun-Choi, K.M. Park, and M.K. Pyo Epinephrine induced platelet aggregation in rat platelet-rich plasma Thrombosis Research 100 2000 511 518